Summary:
Are you one of over 29 million people diagnosed with Type 2 Diabetes and looking for new treatment options? If so, CTT is conducting a new research study testing the safety and effectiveness of an investigational insulin when compared to Humalog in patients with Type 2 Diabetes.
Qualified Participants Must:
• Be between 18 and 75 years of age
• Have had type 2 diabetes for at least 6 months
• Additional criteria may apply
Qualified Participants May Receive:
Study-related medical care from a board-certified physician as well as study medication and testing strips at no cost. Compensation up to $660 will be available for time and travel.